EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,515 | +19.5% | 2,326 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $14,654 | -24.1% | 2,326 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $19,306 | -81.1% | 2,326 | -72.1% | 0.00% | -50.0% |
Q4 2020 | $102,314 | +51.0% | 8,325 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $67,766 | -15.2% | 8,325 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $79,920 | -33.4% | 8,325 | +3.4% | 0.00% | -50.0% |
Q4 2019 | $120,020 | +28.1% | 8,055 | -11.9% | 0.00% | 0.0% |
Q3 2019 | $93,675 | +343.4% | 9,139 | +358.6% | 0.00% | – |
Q2 2019 | $21,125 | – | 1,993 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |